Product Code: ETC9963335 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Contraceptive Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Contraceptive Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Contraceptive Market - Industry Life Cycle |
3.4 United States (US) Contraceptive Market - Porter's Five Forces |
3.5 United States (US) Contraceptive Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 United States (US) Contraceptive Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about family planning and contraception methods |
4.2.2 Rising prevalence of sexually transmitted infections (STIs) driving the need for contraceptive usage |
4.2.3 Government initiatives promoting access to contraceptives and reproductive health services |
4.3 Market Restraints |
4.3.1 Social stigmas and cultural barriers surrounding the use of contraceptives |
4.3.2 Regulatory challenges and approval processes for new contraceptive products |
4.3.3 Potential side effects and health risks associated with certain contraceptive methods |
5 United States (US) Contraceptive Market Trends |
6 United States (US) Contraceptive Market, By Types |
6.1 United States (US) Contraceptive Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Contraceptive Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Contraceptive Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 United States (US) Contraceptive Market Revenues & Volume, By Intrauterine Devices (IUD), 2021- 2031F |
6.1.5 United States (US) Contraceptive Market Revenues & Volume, By Condoms, 2021- 2031F |
6.1.6 United States (US) Contraceptive Market Revenues & Volume, By Vaginal Ring, 2021- 2031F |
6.1.7 United States (US) Contraceptive Market Revenues & Volume, By Subdermal Implants, 2021- 2031F |
6.1.8 United States (US) Contraceptive Market Revenues & Volume, By Injectable, 2021- 2031F |
7 United States (US) Contraceptive Market Import-Export Trade Statistics |
7.1 United States (US) Contraceptive Market Export to Major Countries |
7.2 United States (US) Contraceptive Market Imports from Major Countries |
8 United States (US) Contraceptive Market Key Performance Indicators |
8.1 Rate of contraceptive use among sexually active individuals in the US |
8.2 Number of healthcare providers offering contraceptive counseling and services |
8.3 Percentage of the population with access to affordable contraceptive options |
8.4 Level of education and awareness about different contraceptive methods among the target demographic |
8.5 Adoption rate of long-acting reversible contraceptives (LARCs) in the US |
9 United States (US) Contraceptive Market - Opportunity Assessment |
9.1 United States (US) Contraceptive Market Opportunity Assessment, By Product, 2021 & 2031F |
10 United States (US) Contraceptive Market - Competitive Landscape |
10.1 United States (US) Contraceptive Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Contraceptive Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |